6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000019090	2015/11/04	01/11/2015	Reduced form of CoenzymeQ10 for Parkinson's disease - open trial of dose finding test and combinatio ...	Reduced form of CoenzymeQ10 for Parkinson's disease - open trial of dose finding test and combinatio ...	Parkinson's disease	reduced form of CoQ10 300mg 16weeks reduced form of CoQ10 600mg 16weeks reduced form of CoQ10 600mg 16 ...	Juntendo University Koshigaya Hospital	NULL	Complete: follow-up complete	20years-old	80years-old	Male and Female	45	Not selected	Japan
2	NCT01892176 (ClinicalTrials.gov)	June 2012	30/6/2013	Effects of High-dose Coenzyme Q10on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson ...	Effects of High-dose Coenzyme Q10on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson ...	Parkinson Disease	Dietary Supplement: coenzyme q10	National University Hospital, Singapore	NULL	Completed	21 Months	N/A	Both	20	Phase 2/Phase 3	Singapore
3	NCT00740714 (ClinicalTrials.gov)	December 2008	22/8/2008	Effects of Coenzyme Q10 (CoQ) in Parkinson Disease	Effects of Coenzyme Q10 in Parkinson Disease - Phase III	Parkinson Disease	Drug: Coenzyme Q10 with vitamin E;Drug: placebo with vitamin E	Weill Medical College of Cornell University	National Institute of Neurological Disorders and Stroke (NINDS);University of Rochester	Terminated	30 Years	N/A	All	600	Phase 3	United States;Canada
4	NCT00180037 (ClinicalTrials.gov)	September 2003	9/9/2005	Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease	Multicenter, Placebo Controlled, Randomized, Double-Blinded Study: Coenzyme Q10Nanodispersion Versus ...	Parkinson's Disease	Drug: Coenzyme Q10 Nanodispersion (Nanoquinone);Drug: Placebo	Technische Universität Dresden	Deutsche Parkinson-Vereinigung e.V.;MSE Pharmazeutika GmbH, Bad Homburg	Completed	40 Years	75 Years	Both	132	Phase 3	Germany
5	NCT00004731 (ClinicalTrials.gov)	September 1998	25/2/2000	Parkinson's Disease Treatment With Coenzyme Q10	Effects of Coenzyme Q10 in Early Parkinson's Disease	Parkinson's Disease	Drug: Coenzyme Q10	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	30 Years	N/A	Both		Phase 2	United States

First Previous1Next Last